Suppr超能文献

哥伦比亚波哥大低收入地区5岁以下儿童接种肺炎球菌疫苗和流感疫苗的成本效益分析

Cost-Effectiveness Analysis of Pneumococcal and Influenza Vaccines Administered to Children Less Than 5 Years of Age in a Low-Income District of Bogota, Colombia.

作者信息

Lara Carlos, De Graeve Diana, Franco Fabian

机构信息

Department of Economics, University of Antwerp, Antwerp, Belgium.

Department of Economics, University of Antwerp, Antwerp, Belgium.

出版信息

Value Health Reg Issues. 2018 Dec;17:21-31. doi: 10.1016/j.vhri.2018.01.001. Epub 2018 Apr 5.

Abstract

BACKGROUND

The Colombian health authorities introduced the pneumococcal conjugated vaccine and the seasonal influenza vaccine into the national immunization schedule for children in 2009 and 2007, respectively. Despite this, the health authorities continue to be concerned about the high economic and disease burden among children from low-income households caused by these vaccine-preventable diseases.

OBJECTIVES

  1. To evaluate the potential health outcomes of four vaccination strategies for subsidized children younger than 5 years in a low-income district in Colombia from a public, direct medical health care perspective. 2) To perform univariate, multivariate, and probabilistic sensitivity analysis to evaluate the robustness of these results.

METHODS

We built a Markov deterministic cohort model to evaluate five consecutive cohorts across four alternative situations: 1) no vaccination; 2) vaccination with the 10-valent pneumococcal conjugate vaccine (PCV10 vaccine); 3) vaccination with the trivalent inactivated vaccine (TIV) annually; and 4) combined vaccination with PCV10 vaccine and TIV.

RESULTS

The introduction of PCV10 vaccine and TIV and their combined use in particular would be highly cost-effective in comparison to no vaccination. For the combined vaccination with PCV10 vaccine and TIV, the incremental cost-effectiveness ratio would be $1,280 per disability-adjusted life-year (DALY) averted, the total incremental cost of the vaccination program would be $776,800, and it would avert four deaths and 332 DALYs for the five cohorts.

CONCLUSIONS

The introduction of PCV10 vaccine and TIV would be highly cost-effective from a public, direct medical health care perspective. Despite these results, we have not observed decreases in severity or hospitalizations. Our findings highlight the need for further studies of the immunization campaign indicators and socioeconomic indicators for this low-income community.

摘要

背景

哥伦比亚卫生当局分别于2009年和2007年将肺炎球菌结合疫苗和季节性流感疫苗纳入国家儿童免疫规划。尽管如此,卫生当局仍对这些疫苗可预防疾病给低收入家庭儿童带来的高经济和疾病负担感到担忧。

目的

1)从公共直接医疗保健角度评估哥伦比亚一个低收入地区5岁以下补贴儿童的四种疫苗接种策略的潜在健康结果。2)进行单变量、多变量和概率敏感性分析,以评估这些结果的稳健性。

方法

我们构建了一个马尔可夫确定性队列模型,以评估四种替代情况下的五个连续队列:1)不接种疫苗;2)接种10价肺炎球菌结合疫苗(PCV10疫苗);3)每年接种三价灭活疫苗(TIV);4)联合接种PCV10疫苗和TIV。

结果

与不接种疫苗相比,引入PCV10疫苗和TIV,尤其是联合使用,具有很高的成本效益。对于联合接种PCV10疫苗和TIV,每避免一个伤残调整生命年(DALY)的增量成本效益比为1280美元,疫苗接种计划的总增量成本为776,800美元,并且对于五个队列可避免4例死亡和332个DALY。

结论

从公共直接医疗保健角度来看,引入PCV10疫苗和TIV具有很高的成本效益。尽管有这些结果,但我们并未观察到严重程度或住院率的下降。我们的研究结果强调了对这个低收入社区的免疫活动指标和社会经济指标进行进一步研究的必要性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验